Changes this week
Changes detected in the 7 days to Nov 21, 2026
- Notable: Bempedoic Acid/Ezetimibe/High-intensity Statin in Patients Without Cardiovascular Events Recruitment opened
- Notable: Influenza Vaccine (Split Virion), Inactivatedin (Anflu®) Pregnant Women (AnFLU-PREG) Recruitment opened
- Notable: SG1827 Combined With Anti-PD-1/PD-L1 Antibody and Bevacizumab · Advanced Solid Tumors Recruitment opened
- Notable: K-1728 in Advanced Solid Tumors Recruitment opened
- Notable: MK-6916 · Pain After Bunion Removal Surgery (MK-6916-007) Recruitment opened
- Notable: Co-administration of GSK3862995B With GSK5784283 · Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) Recruitment opened
- Notable: INCA33890 · Circulating Tumor DNA-Positive Stage II/III Microsatellite Stable Colorectal Cancer After Curative Resection and Chemotherapy Recruitment opened
- Notable: PP405 in Adult Females With Androgenetic Alopecia Recruitment opened
- Notable: ACE723, A Dual-Payload Antibody Drug Conjugate, · Advanced HCC Who Have Failed or Progressed on Standard Systemic Therapy Containing ICIs Recruitment opened
- Notable: Aleniglipron Hepatic Impairment Study Recruitment opened
- Notable: Lepodisiran (LY3819469) · High Lipoprotein(a) Recruitment opened
- Notable: Research Study Looking Into How a High Dose of s.c. Semaglutide Works With Emptying of the Stomach · Excess Body Weight Recruitment opened
- Notable: Pharmacokinetic/Pharmacodynamic Characteristics and Safety of GZR101-80 Injection With Separately Injected, Simultaneous Doses of GZR33 Injection and Insulin Aspart Recruitment opened
- Notable: CP-PCA07 in Combination With Enzalutamide · Castration-Resistant Prostate Cancer Recruitment opened
- Notable: INCB161734 · Hepatic Impairment Recruitment opened
- Notable: Addition of a New Anti-Cancer Drug, Glofitamab to Usual Chemotherapy for Burkitt and Double Hit Lymphoma Recruitment opened
- Notable: Serene Sleep Palatal Implant System Clinical Confirmatory Trial in Participants Who Snore or Are Diagnosed With Mild-to-moderate Obstructive Sleep Apnea (OSA) Enrolling by invitation only
- Notable: Registry of Exposure to Gepotidacin (PREG) Recruitment opened
- Notable: Robotic Minimally Invasive Benign Hysterectomy Post-Market Clinical Study With the DEXTER Robotic System Recruitment opened
- Notable: Octane Aether for Treating Chronic Low Back Pain Recruitment opened
- Notable: (Called Marstacimab) · Hemophilia A or B Recruitment opened
- Notable: Behavioral and/or Mirabegron · Urinary Symptoms in Parkinson Disease Recruitment opened
- Notable: Oral TLR8 Agonist Selgantolimod on HBsAg · Both Chronic Hepatitis B and HIV Reclassified as terminated (was completed)
- Notable: Epcoritamab in Combination With Dose Adjusted EPOCH-R for High-risk Burkitt Lymphoma (BL), The BEDROCK Study Recruitment opened
- Notable: Advanced Imaging-Guided Standard Versus Dose-Intensified Radiation Therapy · Newly Diagnosed Glioblastoma, SAGA 2.0 Trial Recruitment opened
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates